Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Perrigo, Actelion Tax Targets Abroad for U.S. Drugmakers
Bloomberg
Monday, July 21, 2014 - 9:14am
tags:
Perrigo Company, Actelion, Smith & Nephew, M&A, tax inversions
Gilead Drug Combination Cures Hepatitis C in HIV Patients
Yahoo/Bloomberg
Monday, July 21, 2014 - 9:13am
tags:
Gilead Sciences, HIV, hepatitis C, Sovaldi, Ribavirin
Why AbbVie Inc Is Buying Shire PLC
Motley Fool
Monday, July 21, 2014 - 9:11am
tags:
Shire, AbbVie, M&A
Shire bosses to receive windfalls after takeover by AbbVie
The Guardian, UK
Sunday, July 20, 2014 - 9:51am
tags:
Shire, AbbVie, M&A
Pfizer releases positive results from Phase III trial of BeneFIX to treat hemophilia B
Pharmaceutical Business Review
Sunday, July 20, 2014 - 9:31am
tags:
Pfizer, BeneFix, hemophilia, hemophilia B
Investing to Fight Toilet and Elevator Superbugs
Motley Fool
Sunday, July 20, 2014 - 9:19am
tags:
Durata Therapeutics, Cubist Pharmaceuticals
This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results
Motley Fool
Sunday, July 20, 2014 - 9:14am
tags:
Progenics Pharmaceuticals, Salix, Exelixis, Roche, Amgen, AbbVie, Shire
The Implications of Obesity as a Disability in Europe
Motley Fool
Sunday, July 20, 2014 - 9:10am
tags:
obesity, weight loss, Arena Pharmaceuticals, Belviq, Orexigen, Vivus, Eisai, Qsymia, NB32
Why Does Novartis Want Google’s "Smart" Contact Lens?
Motley Fool
Saturday, July 19, 2014 - 9:30am
tags:
Novartis, Google, blood glucose monitoring, Alcon, devices, diabetes, smart contact lens
Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma
Pipeline Review
Saturday, July 19, 2014 - 9:26am
tags:
daratumumab, Multiple Myeloma
Can Anything Stop Drug Companies From Fleeing The U.S. Tax System?
Forbes
Saturday, July 19, 2014 - 9:23am
tags:
GSK's phase III study of trametinib and dabrafenib combo shows survival benefit compared to vemurafenib
Pharmabiz
Saturday, July 19, 2014 - 9:20am
tags:
trametinib, GSK, vemurafenib, dabrafenib, melanoma
Strides Arcolab invests in Oncobiologics Inc
India TV News, India
Saturday, July 19, 2014 - 9:15am
tags:
Strides Arcolab, Oncobiologics
Rexahn Pharmaceuticals Provides Update on Phase I Supinoxin Trial in Cancer Patients with Solid Tumors
Pharmiweb
Saturday, July 19, 2014 - 9:05am
tags:
Supinoxin, Rexahn
It’s a Good Time to Be a Drugmaker: Why J&J Is Beating Wall Street
Wall St Cheat Sheet
Saturday, July 19, 2014 - 8:54am
tags:
JNJ
Gilead: 50% Upside From Here
Seeking Alpha
Saturday, July 19, 2014 - 8:51am
tags:
Gilead Sciences
StemCells, Inc. Announces Closing of $20 Million Offering
Yahoo/Globe Newswire
Saturday, July 19, 2014 - 8:47am
tags:
StemCells
Why the Market is Wrong About Baxter Stock
Motley Fool
Saturday, July 19, 2014 - 8:45am
tags:
Baxter
An Open Letter To Janet Yellen: Is There A Biotech Bubble?
Forbes
Saturday, July 19, 2014 - 8:44am
tags:
Biotech VCs bet $1.8B in a colossal Q2
Fierce Biotech
Saturday, July 19, 2014 - 12:05am
tags:
biotech, venture capital

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.